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Shigella sonnei is a major contributor to the global burden of diarrhoeal disease, generally associated with dysenteric diar-
rhoea in developed countries but also emerging in developing countries. The reason for the recent success of S. sonnei is
unknown, but is likely catalysed by its ability to acquire resistance against multiple antimicrobials. Between 2011 and 2013,
S. sonnei exhibiting resistance to fluoroquinolones, the first-line treatment recommended for shigellosis, emerged in Bhutan.
Aiming to reconstruct the introduction and establishment of fluoroquinolone-resistant S. sonnei populations in Bhutan, we
performed whole-genome sequencing on 71 S. sonnei samples isolated in Bhutan between 2011 and 2013.We found that
these strains represented an expansion of a clade within the previously described lineage III, found specifically in Central
Asia. Temporal phylogenetic reconstruction demonstrated that all of the sequenced Bhutanese S. sonnei diverged from
a single ancestor that was introduced into Bhutan around 2006. Our data additionally predicted that fluoroquinolone
resistance, conferred by mutations in gyrA and parC, arose prior to the introduction of the founder strain into Bhutan.
Once established in Bhutan, these S. sonnei had access to a broad gene pool, as indicated by the acquisition of extended-
spectrum b-lactamase-encoding plasmids and genes encoding type IV pili. The data presented here outline a model for the
introduction and maintenance of fluoroquinolone-resistant S. sonnei in a new setting. Given the current circulation of fluor-
oquinolone-resistant S. sonnei in Asia, we speculate that this pattern of introduction is being recapitulated across the region
and beyond.
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provided within the article or through supplementary data files.
Data Summary
1. Whole-genome sequence reads of Shigella sonnei used in
this study have been deposited to the European Nucleotide
Archive. The run accession numbers and related metadata
are detailed in Table S1 which has been deposited in
FigShare: http://figshare.com/articles/The_introduction_
and_establish ment_of_fluoroquinolone_resistant_Shigella_
sonnei_ into_Bhutan/1610693
Introduction
It has recently been estimated that the global burden of
diarrhoeal disease in childrenv5 years of age is*1.7 bil-
lion new infections with 0.7 million deaths per year
(Walker et al., 2013). These figures make diarrhoeal dis-
eases, after respiratory tract infections, the second most
common cause of mortality in young children in low-
income countries (Liu et al., 2012; WHO, 2014). Further
contemporary data from the Global Enteric Multicentre
Study, the largest prospective case–control study on pae-
diatric diarrhoeal illnesses in sub-Saharan Africa and
South Asia ever conducted, identified Shigella to be
amongst the most common diarrhoeal pathogens in these
high-incidence settings (Kotloff et al., 2012, 2013).
The members of the genus Shigella are Gram-negative
pathogens that are closely related to Escherichia coli
(Pupo et al., 2000) and cause dysenteric diarrhoea (stools
containing blood and/or mucus) via a cascade of virulence
factors encoded principally on a large signature virulence
plasmid (Sansonetti et al., 1982). The genus contains
four species: Shigella sonnei, Shigella flexneri, Shigella
boydii and Shigella dysenteriae, with S. sonnei and
S. flexneri dominating in developed and developing
countries, respectively. However, this pattern is changing,
as S. sonnei is currently replacing S. flexneri in countries
undergoing economic transition (Vinh et al., 2009;
Thompson et al., 2015). This species replacement has posi-
tive and negative ramifications. By replacing S. flexneri,
which is very diverse with multiple serotypes with respect
to the single serotype S. sonnei (Connor et al., 2015), as
the leading cause of dysentery means that it may be poss-
ible to control disease through vaccination (Levine et al.,
2007). However, S. sonnei is also highly adept at acquiring
antimicrobial resistance genes and resistance-associated
mutations (Huang et al., 2005; Seol et al., 2006; Nguyen
et al., 2010), limiting treatment options and making con-
trol through antimicrobial treatment alone improbable.
Recent advances in whole-genome sequencing (WGS) and
analytical methodologies have enhanced our understand-
ing of the epidemiology, international spread and antimi-
crobial susceptibility trends of S. sonnei (Holt et al.,
2012, 2013). We now know that S. sonnei is formed of
three main lineages (I, II and III), which are all related
to a common ancestor that arose in Europe *400 years
ago (Holt et al., 2012). Lineage III, which is multidrug-
resistant (MDR), now dominates globally (Holt et al.,
2012). We have also previously shown that once intro-
duced into a new geographical region, into an apparently
naive human population, S. sonnei can establish new iso-
lated clonal populations which evolve locally (Holt et al.,
2013). Antimicrobial resistance is a key driver of the
recent S. sonnei global expansions marked by the acqui-
sition of antimicrobial resistance genes and/or mutations
in genes encoding the target proteins for antimicrobials
(Pu et al., 2015).
Impact Statement
The bacterium Shigella sonnei is a major global cause
of diarrhoeal disease. This organism has generally
been associated with infections in developed
countries, but is currently dramatically expanding
into industrializing countries. The mechanisms
underpinning the spread of S. sonnei are not precisely
understood, but we hypothesize that their spread is
partly facilitated by resistance to antimicrobials,
including the current therapeutic choice to combat
Shigella, the fluoroquinolones. To understand how
the fluoroquinolone-resistant S. sonnei may become
established in a new location, we decoded the total
DNA sequences of 71 S. sonnei samples isolated in
Bhutan in South Asia between 2011 and 2013.
We found that these strains were likely descended
from a single isolate that was introduced into
Bhutan around 2006. Furthermore, we additionally
found that fluoroquinolone resistance emerged
prior to the introduction of this founder S. sonnei
into Bhutan and these strains then became estab-
lished, gaining additional genes and resistance to
other antimicrobials. Our data describe how drug-
resistant S. sonnei may become resident in new
locations, and we predict that a similar situation is
occurring currently with the epidemic of fluoroqui-
nolone-resistant S. sonnei in Asia and beyond.
H. C. The and others
2 Microbial Genomics
Bhutan is a lower middle-income country in South Asia,
sandwiched between China and the northwest Indian
states of Assam and West Bengal. In close proximity to
Nepal (v70 km of Indian territory separates the two
countries), Bhutan is a Himalayan nation with an esti-
mated population of 750 000 people, of which the majority
(69 %) live in remote rural locations (Office of the Census
Commissioner – Royal Government of Bhutan, 2006). Like
other low-income countries in the region, diarrhoeal dis-
ease is a major public health problem in Bhutan, and
both S. flexneri and S. sonnei are endemic (Marfin et al.,
1994; Ruekit et al., 2014). Between March 2011 and Octo-
ber 2013, a diarrhoeal disease surveillance study was con-
ducted in the Bhutanese capital, Thimphu. During this
study, there was an increased number of S. sonnei isolated
between June and July. Antimicrobial susceptibility testing,
PFGE and plasmid replicon typing of 29 of these S. sonnei
isolates showed that all were identical by PFGE pattern and
antimicrobial susceptibility (Ruekit et al., 2014). All these
S. sonnei isolates were resistant to ciprofloxacin
(MICi3 mg ml21), which was infrequently observed in
strains circulating globally during the same period
(Ruekit et al., 2014). This study suggested that these
S. sonnei isolates were closely related and may have been
a recent introduction into Bhutan.
To test the hypothesis that these fluoroquinolone-resistant
S. sonnei had recently been introduced to Bhutan and to
further characterize these Bhutanese isolates in the context
of global S. sonnei, we performed WGS on 71 S. sonnei iso-
lated in Bhutan between 2011 and 2013.
Methods
Sample collection. The Research Ethics Board of Health
in Bhutan and the Institutional Review Board of the Walter
Reed Army Institute of Research provided ethical approval
for the study. Stool samples were collected as described
previously (Ruekit et al., 2014). Stool samples were
collected from cases and controls, and cultured on
MacConkey and Hektoen agar, and incubated overnight
at 37 uC. Non-lactose-fermenting colonies were
confirmed to be Shigella by standard biochemical testing;
serotype was identified by O-antigen agglutination
(Denka Seiken).
Stool samples were collected during a diarrhoea surveil-
lance study conducted at the Jigme Dorji Wangchuk
National Referral Hospital (JDWNRH) in Thimphu,
Bhutan, between March 2011 and October 2013, as
described previously (Ruekit et al., 2014). Briefly, children
aged between 3 months and 5 years presenting to
JDWNRH with acute diarrhoea (three or more loose
stools in the previous 24 h, with symptoms lasting
j72 h at time of recruitment) and those with no diar-
rhoeal symptoms in the previous 2 weeks were eligible
for recruitment as cases and controls, respectively
(informed consent permitting).
All Shigella isolates were subjected to antimicrobial suscep-
tibility testing using the disk diffusion method as rec-
ommended by Clinical and Laboratory Standards
Institute guidelines (CLSI, 2012). The following antimicro-
bials were selected for susceptibility testing: azithromycin,
nalidixic acid, ciprofloxacin, ampicillin, trimethoprim/sul-
famethoxazole, ceftriaxone, streptomycin and tetracycline.
WGS. During the surveillance study a total of 112 Shigella
were isolated (74 S. sonnei, 30 S. flexneri, seven S. boydii
and one S. dysenteriae); the 74 S. sonnei were selected for
WGS. The majority (64/74) of the selected S. sonnei were
isolated from symptomatic diarrhoeal stool samples with
the remaining strains isolated from asymptomatic
infections.
Genomic DNAwas extracted from all S. sonnei isolates using
a Wizard Genomic DNA Extraction kit (Promega) accord-
ing to the manufacturer’s recommendations. For each
sample, 2 mg genomic DNA was subjected to WGS on an
Illumina HiSeq2000 platform, following the manufacturer’s
protocols to generate 100 bp paired-end reads (Quail et al.,
2008). All reads were mapped to the reference sequence of
S. sonnei Ss046 (GenBank accession number NC_007384)
using SMALT (version 0.7.4). Candidate SNPs were called
against the reference sequence and filtered using SAMtools
(Li et al., 2009). Low-quality SNPs were removed according
to the following criteria: consensus quality v50, mapping
quality v30, ratio of SNPs to reads at a position v75 %,
read depth v4, number of reads per strand v2, strand
bias v0.001, mapping bias v0.001 or tail bias v0.001.
Three samples failed due to insufficient read depth, resulting
in a final sample set including 71 S. sonnei whole-genome
sequences from Bhutan.
Phylogenetic analysis, temporal analysis and
Bayesian phylogenetic inference. In order to place
the Bhutanese isolates in the context of global diversity,
we aligned the Bhutanese S. sonnei sequences with
publicly available sequences utilized in a previous global
analysis (Holt et al., 2012). An initial phylogeny was
inferred with these data using RAxML under the
GTRGAMMA model. To further assess the relationship
of the Bhutanese isolates within Central Asia, the
previous alignment was then subsampled to include only
the 71 Bhutanese sequences along with 20 other closely
related Central Asia sequences. Previously described
mobile genetic elements (Holt et al., 2012) and potential
recombinant regions were removed from the alignment
using Gubbins (Croucher et al., 2014). Further removal
of gaps, indeterminate bases, invariant sites and 17
Bhutanese sequences that were identical to others in the
dataset resulted in a final alignment of 996 SNPs across
74 taxa. A maximum-likelihood phylogeny was inferred
from these sequences using GARLI (Zwickl, 2006) with
1000 bootstrap replicates under the TVM (transversion)
model of nucleotide substitution, which was determined
to be the best-fit model using jModelTest (Posada, 2008).
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In order to thoroughly examine the population and tem-
poral structure of Bhutanese S. sonnei and the population
from which they emerged, all sequences from Bhutan,
including identical sequences removed in the previous
phylogeny, were aligned with the six most closely related
isolates from other countries and trimmed down to
include only the 544 SNPs present in the alignment of 77
taxa. These data were then utilized for maximum-likeli-
hood reconstruction using PhyML under the TVM+C4
substitution model (Guindon et al., 2010). In order to
investigate whether temporal signal was embedded in the
resulting maximum-likelihood phylogeny, we applied
Path-O-Gen (version 1.4) to assess the linear relationship
between root-to-tip divergence and date of isolation (in
day, month, year).
Bayesian MCMC (Markov Chain Monte Carlo) deployed
in BEAST (version 1.8.0) (Drummond & Rambaut, 2007)
(a) (b)
Fig. 1. The phylogenetic structure of Bhutanese S. sonnei in the context of the global phylogeny and Central Asia clade. (A) Midpoint
rooted maximum-likelihood phylogenetic tree of 183 S. sonnei strains (135 from global collection and 48 from Bhutan) reconstructed
using 5393 SNPs; asterisks indicate bootstrap support values i98 % on major branches. Numbers above major branches represent
ones leading to major lineages (I, II, III and IV). The light blue box highlights the Global III clade; the dark grey box overlaid on the tree high-
lights strains belonging to the Central Asia clade; the smaller, light grey box highlights the primarily Bhutanese Central Asia clade.
(B) Magnified view of the maximum-likelihood phylogenetic tree of the Central Asia clade, including 74 S. sonnei strains (54 from Bhutan
and 20 others for phylogenetic context), reconstructed using 996 SNPs; asterisks indicate bootstrap support values i80 %. The tree is
midpoint rooted for purposes of clarity. Columns to the right of the phylogenetic tree show isolate metadata including: country of isolation
(colours indicated in the key); the presence (dark blue) or absence (light blue) of specific genetic elements and mutations [ln2, spA,
pSSE3, gyrA (S83L), gyrA (D87G), parC(S80I)], or the presence of an alternative mutation (yellow) [gyrA (D87Y)]; and resistance profiles
against ciprofloxacin (CIP) and trimethoprim/sulfamethoxazole (SXT), where resistance is indicated in dark red, susceptibility in light red
and missing data in grey.
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was then used to infer the evolutionary dynamics of the
aforementioned dataset, with a particular focus on Bhuta-
nese S. sonnei. To determine the best-fit priors to the data
at hand, multiple BEAST runs were conducted using the
TVM or GTR nucleotide substitution model with constant,
exponential growth or Bayesian skyline demographic his-
tory priors, in combination with either a strict or a relaxed
molecular clock (uncorrelated lognormal distribution)
(Drummond & Rambaut, 2007). For each BEAST analysis,
marginal likelihood estimation was conducted using both
path sampling and stepping-stone sampling approaches
to facilitate model selection (Baele et al., 2012, 2013).
Bayes factor comparison indicated the TVM+C4 substi-
tution model with a relaxed log-normal molecular clock
and a piecewise Bayesian skyline demographic model as
the best-fit model to the data. Analyses using these priors
were then performed in triplicate using a continuous 100
million generation MCMC chain with samples taken
every 10 000 generations and parameter convergence (indi-
cated by effective sample size values w200) was assessed
in Tracer (version 1.5). LogCombiner (version 1.8) was
used to combine triplicate runs, with removal of 20 %
burn-in.
Gene content analysis. De novo assembly for each read
set was performed using the assembler Velvet (version
1.2.03) and VelvetOptimizer, with each read set mapped
back to each assembly (Zerbino & Birney, 2008). Contigs
v300 bp were discarded. Assemblies were annotated
using the rapid prokaryotic genome annotation tool
Prokka (Seemann, 2014). To identify contigs associated
with the accessory genome, contigs were first-ordered
with S. sonnei Ss046 and its large virulence plasmid
pSS046 as references using ABACAS. The remaining contigs
were visualized and examined in Artemis. Presence of
Fig. 2. Temporal phylogenetic reconstruction of Bhutanese Shigella sonnei between 2011 and 2013.Image shows a maximum clade
credibility phylogenetic reconstruction of S. sonnei isolated primarily in Bhutan over the study period. Distinct subpopulations of Bhuta-
nese S. sonnei are highlighted and indicated by letters. Black circles indicate posterior probability support i80 % on internal nodes. The
asterisk indicates the branch leading to the Bhutanese S. sonnei clade, which represents 22 lineage-defining SNPs. Arrows denote
branches characterized by select substitution events. Columns to the right of the phylogeny show metadata including: season (dark red,
monsoon season: June–September; light red, other), and presence (dark blue) or absence (light blue) of mobile genetic elements, includ-
ing specific genes (qnrS1, blaCTXM-15, pilL–V locus) and plasmids (pHUSEC41-1-like, pSH146_65-like, pHUSEC2011-1-like, IncK).
Grey bars in metadata columns indicate sequences from S. sonnei isolated outside of Bhutan.
Fluoroquinolone-resistant S. sonnei in Bhutan
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specific accessory genetic determinants was confirmed by
BLAST and visualized using ACT (Carver et al., 2008).
For each isolate, the entire resistance gene content (resis-
tome) was identified by mapping the assembly to a manu-
ally curated resistome database as described previously
(Chung The et al., 2015). MLST was performed for all Shi-
gella isolates by profiling the seven MLST genes (adk,
fumC, gyrB, icd, mdh, purA, recA). Mutations in specific
genes were manually assessed by retrieving their alignments
from the annotations and the effects of non-synonymous
mutations were predicted using the SIFT web server
(http://sift.jcvi.org/) (Sim et al., 2012). An in silico plasmid
incompatibility-type PCR was performed using an in-
house script and bespoke primer set.
Results
Bhutanese S. sonnei lies within lineage III
(Central Asia clade)
All S. sonnei (n574) isolated during this study were sub-
jected to WGS; 71 isolates produced sufficient sequence
for analysis. To contextualize the Bhutanese S. sonnei
within the known global S. sonnei population structure,
we constructed a phylogeny that included the Bhutanese
sequences and those from a previous global S. sonnei
sequencing project (Holt et al., 2012); within this phylo-
geny, all Bhutanese S. sonnei fell into a single clade
within lineage III (Central Asia clade), which is a sister
clade to the intercontinental expanding Global III clade
(Fig. 1A). To investigate the phylogenetic relationships
within the Central Asia clade, we concatenated 74 of the
non-duplicate whole-genome sequences, including 54
from Bhutan and 20 selected from other countries.
A maximum-likelihood phylogeny reconstructed from
this alignment showed a close clonal relationship between
the Bhutanese S. sonnei. Showing a similarly close relation-
ship to the Bhutanese isolates, and interspersed within this
clade, were also two isolates from Thailand and Cambodia,
likely representing importations following regional travel
(Fig. 1B).
Temporal phylogenetic reconstruction of
S. sonnei in Bhutan
As there was such a strong temporal signature for the
number of observed mutations in the global S. sonnei
population (Holt et al., 2013), we explored the temporal
structure of the S. sonnei isolated in Bhutan using Bayesian
phylogenetic methods. To do this, the nucleotide substi-
tution rate of the primarily Bhutanese lineage of Central
Table 1. Non-synonymous mutations separating the MRCA of all Bhutanese S. sonnei from other Central Asia clade strains
Gene Mutation Function SIFT score*/effect
cusS G343S Sensory histidine kinase of CusSR, regulating
the expression of the CusCFBA operon
to confer resistance to high copper
and silver concentrations
0.77
ycgB Y125H Unknown function 0
mppA G344R Periplasmic binding component of murein tripeptide
in oligopeptide transport
0
hisC P98S Histidinol-phosphate aminotransferase, catalysing the biosynthesis of
histidine
0.03
eutL A22S Carboxysomal shell protein, structural component of
proteinaceous microcompartment for ethanolamine ammonia lyase
0.5
hycC G538D Component of HycBCDEFG, hydrogenase component (hydrogenase 3)
of formate hydrogenlyase; HycC encodes an
extremely hydrophobic protein with homology to
NADH : ubiquinone oxidoreductase
0
sdaB A407S L-Serine deaminase II, catalysing the conversion
of serine into pyruvate and ammonia
0.33
metC A2T Cystathionine B-lyase and cysteine desulfhydrase, catalysing
the conversion cystathionine to homocysteine
0.7
rbsK A50T Ribokinase responsible for metabolism of D-ribose 0
gyrA D87G DNA gyrase, subunit A Known effect: resistance to fluoroquinolones
parC S80I DNA topoisomerase IV subunit A Known effect: resistance to fluoroquinolones
* SIFT scores #0.05 indicate a significant effect on protein function based on SIFT analysis.
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Asia was determined to be 7.34|1027 substitutions per
site per year [95 % highest posterior density (HPD):
5.87|1027 to 8.83|1027], which is comparable to the
previously calculated substitution rate of S. sonnei lineage
III (Holt et al., 2013). Using these data, we estimate
that the most recent common ancestor (MRCA) of the
Bhutanese S. sonnei existed around 2006 (95 % HPD
2005–2007), with the majority diverging from a hypotheti-
cal MRCA around 2007 (95 % HPD 2005–2008) (Fig. 2).
The results of this analysis were further supported by the
linear relationship between root-to-tip branch length and
date of isolation (R 250.8412). Since its projected intro-
duction in 2006, this S. sonnei lineage diverged into at
least four sublineages (labelled A, B, C and D in Fig. 2),
which have been transmitted endemically within the Bhu-
tanese capital, Thimphu: isolates taken from cases in June/
July 2011 (25/71 isolates) were found to belong to two
subpopulations (A and C). Sublineage B, which was not
represented in June/July 2011, dominated in the sub-
sequent years (Fig. 2).
Mutations specific to Bhutanese S. sonnei
To identify potential genetic mechanisms associated with
diversification of the Bhutanese S. sonnei, we compared
their content of unique SNPs in comparison with the
three most closely related outgroup isolates, taken from
global isolates belonging to the same global lineage but col-
lected outside of Bhutan (Fig. 2). The Bhutanese isolates
were distinguished from these by the presence of 22 line-
age-specific consensus SNPs. Of these 22 SNPs, five fell
in intergenic regions and 17 mapped within predicted
coding sequences; 11 represented non-synonymous and
six were synonymous mutations. The genes bearing non-
synonymous mutations are summarized in Table 1
together with their predicted impact on function. These
include mutations in gyrA and parC associated with anti-
microbial resistance, as well as those located in ycgB,
mppA, hisC and rbsK, as determined by in silico SIFT (see
Methods) analysis. With the exception of ycgB encoding
a protein with unknown function, these genes all encode
proteins predicted to be involved in the metabolism of his-
tidine, ribose and formate, as well as transport of murein
tripeptide (Table 1).
Accessory genome and impact of antimicrobial
resistance genes in Bhutanese S. sonnei
The compositionof the accessory genome can beused to indi-
cate the capacity of the host species to sample the local gene
pool and also to highlight themes in the patterns of acqui-
sition thatmay be under selection.We performed a compara-
tive gene content analysis of Bhutanese and non-Bhutanese
S. sonnei belonging to the Central Asia clade. These data
revealed events that appear to have been pivotal in evolution
and spreadof theCentralAsia clade.Notably, all the isolates of
this clade possessed a specific class 2 integron In2 (dfrA1,
sat1), conferring resistance to trimethoprim and streptothri-
cin. These strains additionally gained the S. sonnei spA plas-
mid carrying sul2, strAB and tetRA genes, which further
expanded the spectrum of antimicrobial resistance to incor-
porate sulphonamides, streptomycin and tetracycline resist-
ance, respectively (Fig. 1B). This resistance gene profile
concurs with the observation made in the previous global
S. sonnei study (Holt et al., 2012). It is of note that the class
2 integron of the Central Asia clade differs from that of
Global III in the absence of aadA1, which confers resistance
to aminoglycosides. Moreover, it was clear that isolates
within this clade have, over time, accumulated chromosomal
mutations conferring fluoroquinolone resistance (Fig. 1B).
From the lineage-specific phylogeny, we predicted that the
first mutation in gyrA (S83L) occurred before 1996, and sup-
Fig. 3. Novel recombinant hybrid colicin biosynthesis cluster encoded on pSSE3.Schematic representation of the colicin biosynthesis
cluster on plasmid pSSE3 in comparison with colicin gene clusters of pColE7-K317 and pColE6-CT14. Grey vertical bars show hom-
ology in DNA sequences (with identity .80 %). The colicin structural gene (cea), immunity gene (cei) and lysis gene (cel) are annotated
as shown. The three domains of the colicin structural gene are shown the key.
Fluoroquinolone-resistant S. sonnei in Bhutan
http://mgen.microbiologyresearch.org 7
plementary mutations in parC (S80I) and secondary
mutations in gyrA (D87G), leading to high-level fluoroquino-
lone resistance, were fixed in the Bhutanese clade prior to its
expansion and diversification in 2006 (Fig. 2).
A further pivotal event in the emergence of this Central
Asia clade prior to its introduction into Bhutan was the fix-
ation of the previously described E-type colicin plasmid
pSSE3 (with 100 % identity in DNA sequence). This E-
type colicin has been shown to be antagonistic against a
variety of diarrhoeogenic E. coli, but not against commen-
sal E. coli (Calcuttawala et al., 2015). Plasmid pSSE3, which
was found in all Bhutanese isolates (Fig. 1B), also carries an
immunity function that protects the host cell against the
activity of the corresponding colicin. Although it was pre-
viously characterized as a ColE3 plasmid by PCR, sequence
analysis of pSSE3 indicated that the colicin biosynthesis
cluster was a novel recombinant hybrid with an undeter-
mined spectrum of activity (Fig. 3). On closer examin-
ation, the first and second domains (translocation and
receptor-binding) of the colicin structural gene (cea) and
the lysis gene (cel) exhibited substantial amino acid
sequence identity (98 %) to that of colicin E7 (ColE7).
The third domain (cytotoxic) encoded by cea was most
closely related to that of ColE6 (94 % protein sequence
identity), predicting that the colicin’s target is actually
16S rRNA rather than DNA, which is the target of the
ColE7 counterpart (Kleanthous, 2010). However, the pro-
duct of the colicin immunity gene (cei) exhibited only
84 % protein sequence identity to that of colicin E6.
Genetic material that was acquired sporadically across the
Central Asia clade within the Bhutanese isolates included
the extended-spectrum b-lactamase (ESBL) gene blaCTXM-
15, which was independently acquired by two S. sonnei on
different incompatibility plasmids (IncK and IncI1), confer-
ring resistance to third-generation cephalosporins (Fig. 2).
The plasmid replication and transfer region of the IncK plas-
mid shared substantial sequence homology with that of the
enteroaggregative E. coli IncI1 plasmid pSERB1. This plas-
mid in the Bhutanese S. sonnei incorporated the type IV
pilus biosynthesis cluster pilL–V (Dudley et al., 2006). For
the S. sonnei containing the IncK plasmid, the blaCTXM-15
gene was encoded along with the fluoroquinolone resistance
enhancement gene qnrS1 on an IS26 transposon. The
S. sonnei IncI1 plasmid (denoted pHUSEC2011-1-like) was
almost identical (i99 % DNA sequence identity) to the
replication, conjugation and type IV pilus biosynthesis clus-
ter pilL–V in pHUSEC2011-1. The pHUSEC2011-1-like
plasmid was also independently acquired by six additional
strains, although in these cases the blaCTXM-15 gene was not
co-transferred (Fig. 2).
Lastly, nine S. sonnei strains isolated from cases occurring in
June/July 2011 acquired an IncB-O plasmid, sharing hom-
ology with the MDR plasmid pHUSEC41-1 originally ident-
ified in an older O104 : H4 enteroaggregative Shiga toxin-
producing E. coli (HUSEC41), which included a type IV
pilus biosynthesis cluster pilL–V identical to that found on
plasmid pSERB1 (Ku¨nne et al., 2012). We further identified
11 S. sonnei strains harbouring a plasmid with homology to
Salmonella enterica plasmid pSH146_65, additionally carry-
ing a distinct type IV pilus cluster pilL–V (Han et al., 2012).
Discussion
Here, we have used WGS to define a population of
S. sonnei causing disease in the South Asian land-locked
nation of Bhutan. These strains belong to an expansion
of lineage III, which we have named the Central Asia
clade, which was introduced into Bhutan around 2006.
To the best of our knowledge, this is the first time that
WGS has been used on this scale to study a population
of S. sonnei in South Asia, a region with a substantial
burden of diarrhoeal disease. In contrast to recent obser-
vations from Vietnam, the sequenced S. sonnei in Bhutan
demonstrated no evidence of a single clonal expansion.
This is perhaps due to the short sampling time frame or
other factors such as the lack of a definitive selective
sweep event. However, the evolution history of Central
Asia clade S. sonnei resembles the two initial sweep
events observed in Vietnam [associated with fixation of a
colicin plasmid and mutation(s) in gyrA ] (Holt et al.,
2013), showing that the two geographically and phylogeni-
cally unrelated S. sonnei populations followed a similar
evolutionary trajectory. After its introduction to Bhutan,
our data predict that these S. sonnei had access to a sub-
stantial gene pool, as indicated by the sporadic acquisition
of ESBL plasmids and type IV pili. The gains of ESBL plas-
mids, although infrequent, could potentially become the
next selective sweep for the Bhutan’s S. sonnei population
as observed in Vietnam, given the selection path toward
resistance is maintained. The characteristically thin type
IV pilus has been shown to improve the efficiency and
specificity of conjugation in liquid environments (Kim &
Komano, 1997), and also facilitates adherence, interbacter-
ial contact and twitching motility (Berry & Pelicic, 2015).
Although this structure is known to be widespread in pro-
karyotes, its impact on the lifestyle of Shigella is not well
described and requires further experimental investigation
(Holt et al., 2013; Rohmer et al., 2014).
In addition, the Bhutanese S. sonnei population is charac-
terized by the presence of numerous non-synonymous
mutations, most of which are found in metabolic path-
ways. The genus Shigella is well known for its adaptive
intracellular lifestyle, enabling its shedding of redundant
or unnecessary functions during the course of evolution
(Prosseda et al., 2012). Our in silico analysis predicted
that some mutations could affect metabolic activities,
which could lead to degradation. In particular, the affected
D-ribose utilization and formate fermentation appear to be
redundant as energy production in Shigella predominantly
occurs via the uptake and metabolism of pyruvate into
acetate (Kentner et al., 2014). Biosynthesis of histidine is
also deemed inessential as the bacterium could readily
transport it from the host’s cytosol. However, the true
H. C. The and others
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impacts of the aforementioned mutations should be con-
firmed by functional analyses in vitro in future studies.
We were able to use WGS to identify the major events
during the evolution of this lineage prior to, and after,
its introduction into a new setting. Our data imply that
the acquisition of a class 2 integron and a spA plasmid,
together with the rapid accumulation of mutations
associated with fluoroquinolone resistance, rendered the
Bhutanese S. sonnei MDR by 2006. Furthermore, a fluoro-
quinolone-resistant subclade within the Central Asia clade
was predicted to have arisen between 1999 and 2006.
In addition, the fixation of a novel recombinant colicin E
plasmid (pSSE3) may have offered this group of pathogens
a competitive advantage over other enteric bacteria, similar
to the colicin-associated selective sweep observed in
S. sonnei in Vietnam (Holt et al., 2013). These data suggest
that whilst antimicrobial resistance is clearly important, it
is not sufficient in itself for driving the spread of new
clones and anticompetitive functions appear to be key
themes in the spread of MDR S. sonnei.
Our data additionally suggests that international travel
may have resulted in the dissemination of Central Asia
clade S. sonnei beyond Bhutan and the remainder of the
Indian subcontinent. S. sonnei isolates with similar PFGE
patterns to the strains in this analysis have been recovered
from cases of travel-associated shigellosis in Ireland (De
Lappe et al., 2015) and in a Shigella outbreak amongst
‘men who have sex with men’ in Canada (Gaudreau
et al., 2011). The S. sonnei isolated from both instances
were found to be ciprofloxacin-resistant. Studies con-
ducted in Japan have established a strong association
between this pulsotype and travel to India, and increasing
prevalence of nalidixic acid-resistant S. sonnei has been
observed since 2001 (Uchimura et al., 2001; Izumiya
et al., 2009). Shigellosis surveys in Iran conducted from
2008 to 2012 have repeatedly shown that this characteristic
Asian pulsotype is prevalent and endemic, and that these
strains also possess a similar class 2 integron (dfrA1,
sat1), but exhibit variability in their ciprofloxacin suscep-
tibility phenotype (Tajbakhsh et al., 2012; Eftekhari et al.,
2013; Alizadeh-Hesar et al., 2015). The first case of fluor-
oquinolone-resistant S. sonnei was identified in Japan in
1993 (Horiuchi et al., 1993). Since then, the incidence of
ciprofloxacin-resistant Shigella in Asia and Africa has
risen dramatically, from 3.9 % in 2001–2003 to 29.1 %
in 2007–2009 (Gu et al., 2012). The potential emergence
and dissemination of fluoroquinolone-resistant S. sonnei
poses a substantial threat to public health, including low
shigellosis burden areas in developed nations, as again
substantiated by the recent fluoroquinolone-resistant
S. sonnei outbreak in the USA (Bowen et al., 2015).
Taken together, these data strongly suggest that the Cen-
tral Asia clade of S. sonnei is widely present across South
Asia and beyond, and may represent an emerging threat
to public health.
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